Evoke Pharma Total Liabilities and Share Holders Equity 2012-2024 | EVOK
Evoke Pharma total liabilities and share holders equity from 2012 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Evoke Pharma Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$12 |
| 2021 |
$11 |
| 2020 |
$9 |
| 2019 |
$6 |
| 2018 |
$6 |
| 2017 |
$8 |
| 2016 |
$9 |
| 2015 |
$10 |
| 2014 |
$15 |
| 2013 |
$25 |
| 2012 |
$0 |
| 2011 |
$1 |
Evoke Pharma Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-09-30 |
$14 |
| 2024-06-30 |
$12 |
| 2024-03-31 |
$12 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$9 |
| 2023-03-31 |
$10 |
| 2022-12-31 |
$12 |
| 2022-09-30 |
$13 |
| 2022-06-30 |
$14 |
| 2022-03-31 |
$9 |
| 2021-12-31 |
$11 |
| 2021-09-30 |
$12 |
| 2021-06-30 |
$18 |
| 2021-03-31 |
$19 |
| 2020-12-31 |
$9 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$8 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$7 |
| 2019-06-30 |
$8 |
| 2019-03-31 |
$4 |
| 2018-12-31 |
$6 |
| 2018-09-30 |
$7 |
| 2018-06-30 |
$7 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
$8 |
| 2017-09-30 |
$11 |
| 2017-06-30 |
$13 |
| 2017-03-31 |
$15 |
| 2016-12-31 |
$9 |
| 2016-09-30 |
$11 |
| 2016-06-30 |
$5 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$10 |
| 2015-09-30 |
$12 |
| 2015-06-30 |
$11 |
| 2015-03-31 |
$13 |
| 2014-12-31 |
$15 |
| 2014-09-30 |
$13 |
| 2014-06-30 |
$17 |
| 2014-03-31 |
$23 |
| 2013-12-31 |
$25 |
| 2013-09-30 |
$24 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
